VSIR and ovarian carcinoma: Indeed, it has been proven that VISTA has a worse prognosis in multiple types of cancers, for instance, ovarian cancer, human non-small cell lung cancer, cutaneous melanoma, glioma, and colon cancer (15, 27, 29, 31, 32).